Q32 Bio (QTTB) Free Cash Flow (2017 - 2026)

Q32 Bio's Free Cash Flow history runs 10 years deep, the most recent figure standing at -$6.3 million for Q1 2026.

• On a quarterly basis, Free Cash Flow rose 50.48% year-over-year to -$6.3 million in Q1 2026; TTM through Mar 2026 was -$28.0 million, a 57.97% increase from a year earlier, with the FY2025 full-year figure at -$34.5 million, up 49.68% from the prior year.
• Free Cash Flow rose to -$6.3 million in Q1 2026 per QTTB's latest filing, from -$7.3 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $15.9 million in Q3 2023 and bottomed at -$32.1 million in Q2 2022.
• The 5-year median for Free Cash Flow is -$12.5 million (2023), against an average of -$14.3 million.
• Across the five-year window, Free Cash Flow surged 163.76% in 2023 and sank 226.47% in 2024, its largest moves.
• Year by year, Free Cash Flow stood at -$27.2 million in 2022, then jumped by 60.62% to -$10.7 million in 2023, then decreased by 9.02% to -$11.7 million in 2024, then surged by 37.88% to -$7.3 million in 2025, then increased by 12.59% to -$6.3 million in 2026.
• Per Business Quant, the three latest QTTB Free Cash Flow figures stand at -$6.3 million (Q1 2026), -$7.3 million (Q4 2025), and -$3.6 million (Q3 2025).